We serve Chemical Name:ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate CAS:119031-24-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate
CAS.NO:119031-24-2
Synonyms:ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate
Molecular Formula:C17H16O4
Molecular Weight:284.30700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:52.60000
Exact Mass:284.10500
LogP:3.61480
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate Use and application,ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate technical grade,usp/ep/jp grade.
Related News: One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate manufacturer One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate supplier It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate vendor The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. ethyl 3-oxo-3-(2-phenoxyphenyl)propanoate factory The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said.